President Trump Reschedules Marijuana to Schedule III: Impact on Canopy Growth, Green Thumb, and Tilray
In April 2026, President Donald Trump's executive order led to marijuana being rescheduled from Schedule I to Schedule III by the DEA. However, this change only applied to medical marijuana, leaving recreational use still classified as Schedule I. The move has limited market impact for cannabis companies like Canopy Growth (NASDAQ: CGC), Tilray Brands (NASDAQ: TLRY), and Green Thumb Industries (OTC: GTBIF).
Topics: DEA federal law marijuana rescheduling